RaySearch Laboratories AB (publ)
RSLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,899 | $10,336 | $7,741 | $7,240 |
| - Cash | $323 | $403 | $503 | $463 |
| + Debt | $411 | $430 | $449 | $472 |
| Enterprise Value | $8,987 | $10,363 | $7,687 | $7,249 |
| Revenue | $332 | $305 | $332 | $323 |
| % Growth | 9% | -8.1% | 2.8% | – |
| Gross Profit | $321 | $277 | $305 | $298 |
| % Margin | 96.4% | 90.8% | 92% | 92.3% |
| EBITDA | $89 | $36 | $75 | $74 |
| % Margin | 26.8% | 11.9% | 22.6% | 22.8% |
| Net Income | $72 | $31 | $57 | $60 |
| % Margin | 21.5% | 10.1% | 17.1% | 18.6% |
| EPS Diluted | 2.09 | 0.9 | 1.66 | 1.75 |
| % Growth | 132.2% | -45.8% | -5.1% | – |
| Operating Cash Flow | -$12 | $71 | $147 | $103 |
| Capital Expenditures | -$51 | -$53 | -$62 | -$61 |
| Free Cash Flow | -$63 | $18 | $85 | $42 |